uniQure NV (HAM:UQ1)
€ 40.55 +1.75 (+4.51%) Market Cap: 2.79 Bil Enterprise Value: 2.15 Bil PE Ratio: 0 PB Ratio: 9.93 GF Score: 48/100

Q1 2026 Uniqure NV Earnings Call Transcript

May 05, 2026 / 12:30PM GMT
Release Date Price: €17.54 (+9.76%)
Operator

Thank you for standing by. My name is Liz, and I'll be your conference operator today. At this time, I would like to welcome everyone to the uniQure first-quarter 2026 earnings call. (Operator Instructions)

I would now like to turn the call over to Chiara Russo, Senior Director of Investor Relations. Please go ahead.

Chiara Russo
Uniqure NV - IR Contact Officer

Good morning, and thank you for joining us for uniQure's first-quarter of 2026 earnings call. Earlier this morning, uniQure released its financial results for the first quarter of 2026, and our press release is available on the Investors and Media section of our website at uniqure.com.

Our 10-Q was also filed with the SEC earlier today. Joining me on the call this morning are Matt Kapusta, Chief Executive Officer; Dr. Walid Abi-Saab, Chief Medical Officer; Kylie O'Keefe, Chief Customer and Strategy Officer; and Christian Klemt, Chief Financial Officer.

After our formal remarks, we'll open the call up for Q&A. Before we begin, please note that we will be making forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot